Indication
Malignant glioma
Malignant glioma refers to a group of aggressive, high-grade primary central nervous system neoplasms arising from glial support cells, primarily astrocytes and oligodendrocytes. Read more about Malignant glioma
18 drugs 16 manufacturers
Drugs that treat it
Common Malignant glioma therapies.
CARMUSTINE
CARMUSTINE
CARMUSTINE
CARMUSTINE
GLIADEL (carmustine in polifeprosan 20)
CARMUSTINE
CARMUSTINE
CARMUSTINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMalignant glioma refers to a group of aggressive, high-grade primary central nervous system neoplasms arising from glial support cells, primarily astrocytes and oligodendrocytes.
Most frequently diagnosed in adults but also occurring in pediatric populations, these tumors primarily affect the brain and, less commonly, the spinal cord.
Pathophysiologically, they encompass World Health Organization grade 3 and 4 malignancies—most notably glioblastoma and anaplastic gliomas—characterized by rapid cellular proliferation, diffuse parenchymal infiltration, robust microvascular proliferation, necrosis, and high rates of recurrence.
Clinically, they manifest with signs of elevated intracranial pressure, intractable headaches, new-onset seizures, cognitive decline, and progressive focal neurological deficits corresponding to the neuroanatomical site of the lesion.
- cancer.gov
Malignant glioma refers to a group of aggressive, high-grade primary central nervous system neoplasms arising from glial support cells, primarily astrocytes and oligodendrocytes Most frequently diagnosed in adults but also occurring in pediatric populations, these tumors primarily affect the brain and, less commonly, the spinal cord
- nih.gov
Malignant glioma refers to a group of aggressive, high-grade primary central nervous system neoplasms arising from glial support cells, primarily astrocytes and oligodendrocytes Most frequently diagnosed in adults but also occurring in pediatric populations, these tumors primarily affect the brain and, less commonly, the spinal cord Pathophysiologically, they encompass World Health Organization grade 3 and 4 malignancies—most notably glioblastoma and anaplastic gliomas—characterized by rapid cel...
- nih.gov
Most frequently diagnosed in adults but also occurring in pediatric populations, these tumors primarily affect the brain and, less commonly, the spinal cord
- utah.edu
Most frequently diagnosed in adults but also occurring in pediatric populations, these tumors primarily affect the brain and, less commonly, the spinal cord
- nih.gov
Pathophysiologically, they encompass World Health Organization grade 3 and 4 malignancies—most notably glioblastoma and anaplastic gliomas—characterized by rapid cellular proliferation, diffuse parenchymal infiltration, robust microvascular proliferation, necrosis, and high rates of recurrence
- nih.gov
Pathophysiologically, they encompass World Health Organization grade 3 and 4 malignancies—most notably glioblastoma and anaplastic gliomas—characterized by rapid cellular proliferation, diffuse parenchymal infiltration, robust microvascular proliferation, necrosis, and high rates of recurrence Clinically, they manifest with signs of elevated intracranial pressure, intractable headaches, new-onset seizures, cognitive decline, and progressive focal neurological deficits corresponding to the neuroa...
- gleolan.com
Pathophysiologically, they encompass World Health Organization grade 3 and 4 malignancies—most notably glioblastoma and anaplastic gliomas—characterized by rapid cellular proliferation, diffuse parenchymal infiltration, robust microvascular proliferation, necrosis, and high rates of recurrence
- mayoclinic.org
Clinically, they manifest with signs of elevated intracranial pressure, intractable headaches, new-onset seizures, cognitive decline, and progressive focal neurological deficits corresponding to the neuroanatomical site of the lesion
Personalize your experience
Follow Malignant glioma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.